These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9172287)
1. A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activation. Orning L; Stephens RW; Petersen LB; Hamers MJ; Stormorken H; Sakariassen KS Thromb Res; 1997 Apr; 86(1):57-67. PubMed ID: 9172287 [TBL] [Abstract][Full Text] [Related]
2. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation. Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442 [TBL] [Abstract][Full Text] [Related]
3. Peptides corresponding to the second epidermal growth factor-like domain of human blood coagulation factor VII: synthesis, folding and biological activity. Husbyn M; Orning L; Sakariassen KS; Fischer PM J Pept Res; 1997 Dec; 50(6):475-82. PubMed ID: 9440049 [TBL] [Abstract][Full Text] [Related]
4. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII. Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological activity, and solution structures of a cyclic dodecapeptide from the EGF-2 domain of blood coagulation factor VII. Hu CK; Llinás M; Agner KE; Orning L; Sakariassen KS; Fischer PM J Pept Res; 2001 Jun; 57(6):462-72. PubMed ID: 11437950 [TBL] [Abstract][Full Text] [Related]
6. Characterization of porcine factor VII, X and comparison with human factor VII, X. Chen Y; Qiao J; Tan W; Lu Y; Qin S; Zhang J; Li S; Bu H; Cheng J Blood Cells Mol Dis; 2009; 43(1):111-8. PubMed ID: 19286401 [TBL] [Abstract][Full Text] [Related]
7. Solution structure of the N-terminal EGF-like domain from human factor VII. Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950 [TBL] [Abstract][Full Text] [Related]
8. High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII. Inoue K; Shimada H; Ueba J; Enomoto S; Tanaka-Saisaka Y; Kubota T; Koyama M; Morita T Biochemistry; 1996 Oct; 35(43):13826-32. PubMed ID: 8901525 [TBL] [Abstract][Full Text] [Related]
9. Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex. Rønning HF; Risøen UC; Orning L; Sletten K; Sakariassen KS Thromb Res; 1996 Oct; 84(2):73-81. PubMed ID: 8897697 [TBL] [Abstract][Full Text] [Related]
10. Structural requirements for the interaction between tissue factor and factor VII: characterization of chymotrypsin-derived tissue factor polypeptides. O'Brien DP; Anderson JS; Martin DM; Byfield PG; Tuddenham EG Biochem J; 1993 May; 292 ( Pt 1)(Pt 1):7-12. PubMed ID: 8503864 [TBL] [Abstract][Full Text] [Related]
11. Identification of molecular sites on factor VII which mediate its assembly and function in the extrinsic pathway activation complex. Kumar A; Blumenthal DK; Fair DS J Biol Chem; 1991 Jan; 266(2):915-21. PubMed ID: 1985971 [TBL] [Abstract][Full Text] [Related]
12. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor. Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain. Kavlie A; Orning L; Grindflek A; Stormorken H; Prydz H Thromb Haemost; 1998 Jun; 79(6):1136-43. PubMed ID: 9657438 [TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal anti-human factor VII antibody (B101/B1) that recognized three-dimensional structures near Arg at position 79 in the first EGF-like domain. Takamiya O Thromb Haemost; 1998 Jan; 79(1):104-9. PubMed ID: 9459333 [TBL] [Abstract][Full Text] [Related]
15. Linear analogues derived from the first EGF-like domain of human blood coagulation factor VII: enhanced inhibition of FVIIa/TF complex activity by backbone modification through aspartimide formation. Husbyn M; Orning L; Cuthbertson A; Fischer PM J Pept Sci; 1999 Jul; 5(7):323-9. PubMed ID: 10442768 [TBL] [Abstract][Full Text] [Related]
16. Specific molecular interaction sites on factor VII involved in factor X activation. Kumar A; Fair DS Eur J Biochem; 1993 Oct; 217(2):509-18. PubMed ID: 8223595 [TBL] [Abstract][Full Text] [Related]
17. Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII. Williamson V; Pyke A; Sridhara S; Kelley RF; Blajchman MA; Clarke BJ J Thromb Haemost; 2005 Jun; 3(6):1250-6. PubMed ID: 15892860 [TBL] [Abstract][Full Text] [Related]
18. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Broze GJ Semin Hematol; 1992 Jul; 29(3):159-69. PubMed ID: 1641662 [No Abstract] [Full Text] [Related]
19. Selection and characterization of a new class of peptide exosite inhibitors of coagulation factor VIIa. Dennis MS; Roberge M; Quan C; Lazarus RA Biochemistry; 2001 Aug; 40(32):9513-21. PubMed ID: 11583150 [TBL] [Abstract][Full Text] [Related]
20. A novel gene mutation in the 60s loop of human coagulation factor VII - inhibition of interdomain crosstalk. Kavlie A; Wiiger MT; Husbyn M; Stormorken H; Prydz H Thromb Haemost; 2004 Jan; 91(1):28-37. PubMed ID: 14691565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]